
|Articles|December 15, 2002
Transplant Relief
Paris - Topical imiquimod offers safe and often effective treatment for basal cell carcinomas (BCCs) in immunosuppressed, solid organ transplantation patients, David Vidal, M.D., said at the World Congress of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001
2
New Clinical Insights Into Hair Loss Disorders and the Vitamin D Receptor
3
French Early Access Data on Dupilumab in Pediatric Atopic Dermatitis
4
Phase 2a Evaluation of Dual OX40L/TNFα Antibody Begins in HS
5


















